InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: None

Thursday, 09/22/2016 12:36:28 PM

Thursday, September 22, 2016 12:36:28 PM

Post# of 118414
Since FDA has designated Aplastic Anemia with Orphan Drug status in the past to other entities, anyone have any insight as to why they would not grant it to RGBP and why it would take 6-8 months for RGBP to be able to respond to the FDA since I believe they filed for Orphan Drug status back in Jan 2016?